HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer (Q46713075)

3 July 2018

title

HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer (English)

1 reference

3 July 2018

0 references

8

Funda Meric-Bernstam

1 reference

3 July 2018

Julie E Lang

1

1 reference

3 July 2018

Kailash Mosalpuria

2

1 reference

3 July 2018

Massimo Cristofanilli

3

1 reference

3 July 2018

Savitri Krishnamurthy

4

1 reference

3 July 2018

James Reuben

5

1 reference

3 July 2018

Balraj Singh

6

1 reference

3 July 2018

Isabelle Bedrosian

7

1 reference

3 July 2018

Anthony Lucci

9

1 reference

3 July 2018

language of work or name

English

0 references

publication date

9 March 2008

1 reference

3 July 2018

Breast Cancer Research and Treatment

published in

1 reference

3 July 2018

volume

113

1 reference

3 July 2018

issue

3

1 reference

3 July 2018

page(s)

501-507

1 reference

3 July 2018

https://scigraph.springernature.com/pub.10.1007/s10549-008-9951-2

exact match

0 references

cites work

Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Quantitative intracellular molecular profiling using a one-dimensional flow system

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

HER-2 gene amplification can be acquired as breast cancer progresses

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Circulating tumour cells in breast cancer

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Detection and characterization of carcinoma cells in the blood

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

A pooled analysis of bone marrow micrometastasis in breast cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Reporting recommendations for tumor marker prognostic studies (REMARK).

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5847290

Statistical considerations for enumeration of circulating tumor cells

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10549-008-9951-2

Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood

21 January 2018

1 reference

12 December 2020

Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer

1 reference

12 December 2020

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

1 reference

12 December 2020

Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes

1 reference

12 December 2020

Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells

1 reference

12 December 2020

Prognostic value of tumour cell detection in peripheral blood of breast cancer patients

1 reference

12 December 2020

Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy

1 reference

12 December 2020

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients

1 reference

12 December 2020

Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden

1 reference

12 December 2020

10.1007/S10549-008-9951-2

Identifiers

DOI

1 reference

3 July 2018

PMCID

5847290

1 reference

3 July 2018

PubMed ID

18327638

1 reference

3 July 2018